- Home
- VYNE vs TELA Comparison
VYNE vs TELA Comparison
Compare VYNE & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- TELA
- Stock Information
- Founded
- VYNE 2003
- TELA 2012
- Country
- VYNE United States
- TELA United States
- Employees
- VYNE N/A
- TELA N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- TELA Medical/Dental Instruments
- Sector
- VYNE Health Care
- TELA Health Care
- Exchange
- VYNE Nasdaq
- TELA Nasdaq
- Market Cap
- VYNE 35.7M
- TELA 36.4M
- IPO Year
- VYNE 2018
- TELA 2019
- Fundamental
- Price
- VYNE $1.30
- TELA $1.08
- Analyst Decision
- VYNE Strong Buy
- TELA Strong Buy
- Analyst Count
- VYNE 2
- TELA 4
- Target Price
- VYNE $6.25
- TELA $6.00
- AVG Volume (30 Days)
- VYNE 222.4K
- TELA 88.2K
- Earning Date
- VYNE 05-08-2025
- TELA 05-08-2025
- Dividend Yield
- VYNE N/A
- TELA N/A
- EPS Growth
- VYNE N/A
- TELA N/A
- EPS
- VYNE N/A
- TELA N/A
- Revenue
- VYNE $605,000.00
- TELA $71,217,000.00
- Revenue This Year
- VYNE N/A
- TELA $25.90
- Revenue Next Year
- VYNE N/A
- TELA $23.00
- P/E Ratio
- VYNE N/A
- TELA N/A
- Revenue Growth
- VYNE 43.03
- TELA 12.78
- 52 Week Low
- VYNE $1.27
- TELA $0.87
- 52 Week High
- VYNE $4.30
- TELA $6.50
- Technical
- Relative Strength Index (RSI)
- VYNE 34.90
- TELA 47.00
- Support Level
- VYNE $1.27
- TELA $0.93
- Resistance Level
- VYNE $1.41
- TELA $1.07
- Average True Range (ATR)
- VYNE 0.12
- TELA 0.08
- MACD
- VYNE -0.01
- TELA 0.05
- Stochastic Oscillator
- VYNE 5.46
- TELA 82.38
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.